BRIEF-U.S. FDA approves Amjevita, a biosimilar to Humira
September 23, 2016 at 17:10 PM EDT
* Approved Amjevita (Adalimumab-Atto) as a biosimilar to Humira (Adalimumab) for multiple inflammatory diseases Source text for Eikon:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.